XDR-TB is defined as Resistance to –
So the core concept here is the definition of XDR-TB. The question is asking which drugs' resistance defines XDR-TB. The correct answer should mention resistance to isoniazid, rifampicin, any fluoroquinolone, and a second-line injectable. Let me check the options again. The user didn't provide the options, but I need to structure the explanation based on the correct answer. Assuming the correct answer is an option that includes all these drugs, the explanation would focus on that.
Now, for the wrong options. Common mistakes might include thinking that XDR-TB only requires resistance to first-line drugs plus one second-line, but actually, it's two categories: first-line plus fluoroquinolone and injectable. Another incorrect option might list different drugs or miss one of the categories. For example, an option that includes resistance to isoniazid, rifampicin, and streptomycin would be wrong because streptomycin is a first-line injectable, but XDR requires resistance to second-line injectables.
The clinical pearl here is to remember that XDR-TB is MDR-TB plus resistance to fluoroquinolones and injectables. That's a key differentiator from MDR-TB. Mnemonics could help: "XDR = MDR + FQ + injectable." Also, knowing that XDR-TB is a public health concern because treatment options are very limited, leading to higher mortality rates.
I need to make sure the explanation is concise but covers all the necessary points. Use precise terms like fluoroquinolones (e.g., levofloxacin, moxifloxacin) and second-line injectables. Avoid confusion between first and second-line drugs. Also, clarify that XDR-TB is more restrictive than MDR-TB, so the resistance criteria are broader.
**Core Concept**
XDR-TB (Extensively Drug-Resistant Tuberculosis) is a form of *Mycobacterium tuberculosis* resistance defined by the World Health Organization (WHO). It requires resistance to **first-line drugs (isoniazid and rifampicin)**, **any fluoroquinolone**, and **at least one second-line injectable agent (amikacin, kanamycin, capreomycin)**. This classification highlights the limited therapeutic options compared to MDR-TB.
**Why the Correct Answer is Right**
XDR-TB is diagnosed when the isolate is resistant to **isoniazid and rifampicin**, the cornerstone first-line drugs, plus **any fluoroquinolone** (e.g.,